These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
331 related items for PubMed ID: 21036696
1. Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation. Grudzien P, Lo S, Albain KS, Robinson P, Rajan P, Strack PR, Golde TE, Miele L, Foreman KE. Anticancer Res; 2010 Oct; 30(10):3853-67. PubMed ID: 21036696 [Abstract] [Full Text] [Related]
2. Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model. Efferson CL, Winkelmann CT, Ware C, Sullivan T, Giampaoli S, Tammam J, Patel S, Mesiti G, Reilly JF, Gibson RE, Buser C, Yeatman T, Coppola D, Winter C, Clark EA, Draetta GF, Strack PR, Majumder PK. Cancer Res; 2010 Mar 15; 70(6):2476-84. PubMed ID: 20197467 [Abstract] [Full Text] [Related]
3. Gamma-secretase inhibitors target tumor-initiating cells in a mouse model of ERBB2 breast cancer. Kondratyev M, Kreso A, Hallett RM, Girgis-Gabardo A, Barcelon ME, Ilieva D, Ware C, Majumder PK, Hassell JA. Oncogene; 2012 Jan 05; 31(1):93-103. PubMed ID: 21666715 [Abstract] [Full Text] [Related]
4. Notch Signaling in Breast Cancer: A Role in Drug Resistance. BeLow M, Osipo C. Cells; 2020 Sep 29; 9(10):. PubMed ID: 33003540 [Abstract] [Full Text] [Related]
5. Apoptosis in T cell acute lymphoblastic leukemia cells after cell cycle arrest induced by pharmacological inhibition of notch signaling. Lewis HD, Leveridge M, Strack PR, Haldon CD, O'neil J, Kim H, Madin A, Hannam JC, Look AT, Kohl N, Draetta G, Harrison T, Kerby JA, Shearman MS, Beher D. Chem Biol; 2007 Feb 29; 14(2):209-19. PubMed ID: 17317574 [Abstract] [Full Text] [Related]
6. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Fan X, Matsui W, Khaki L, Stearns D, Chun J, Li YM, Eberhart CG. Cancer Res; 2006 Aug 01; 66(15):7445-52. PubMed ID: 16885340 [Abstract] [Full Text] [Related]
7. Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6-Abundant Breast Cancer Cells by Regulating γ-Secretase-Mediated Notch1 Activation in Caveolae. Hsu EC, Kulp SK, Huang HL, Tu HJ, Salunke SB, Sullivan NJ, Sun D, Wicha MS, Shapiro CL, Chen CS. Neoplasia; 2015 Jun 01; 17(6):497-508. PubMed ID: 26152358 [Abstract] [Full Text] [Related]
8. Targeting notch to eradicate pancreatic cancer stem cells for cancer therapy. Wang Z, Ahmad A, Li Y, Azmi AS, Miele L, Sarkar FH. Anticancer Res; 2011 Apr 01; 31(4):1105-13. PubMed ID: 21508353 [Abstract] [Full Text] [Related]
13. Neuropilin-1 is expressed by breast cancer stem-like cells and is linked to NF-κB activation and tumor sphere formation. Glinka Y, Mohammed N, Subramaniam V, Jothy S, Prud'homme GJ. Biochem Biophys Res Commun; 2012 Sep 07; 425(4):775-80. PubMed ID: 22885184 [Abstract] [Full Text] [Related]
16. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers. Konishi J, Kawaguchi KS, Vo H, Haruki N, Gonzalez A, Carbone DP, Dang TP. Cancer Res; 2007 Sep 01; 67(17):8051-7. PubMed ID: 17804716 [Abstract] [Full Text] [Related]
17. Notch pathway as candidate therapeutic target in Her2/Neu/ErbB2 receptor-negative breast tumors. Hirose H, Ishii H, Mimori K, Ohta D, Ohkuma M, Tsujii H, Saito T, Sekimoto M, Doki Y, Mori M. Oncol Rep; 2010 Jan 01; 23(1):35-43. PubMed ID: 19956862 [Abstract] [Full Text] [Related]
19. [Signal pathways in breast cancer stem cells and the targeted stem cell therapy]. Ma Y, Wang HX. Zhonghua Zhong Liu Za Zhi; 2010 Dec 01; 32(12):881-5. PubMed ID: 21223793 [No Abstract] [Full Text] [Related]